4//SEC Filing
Otvos James D. 4
Accession 0001209191-13-005164
CIK 0001168197other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:14 PM ET
Size
8.1 KB
Accession
0001209191-13-005164
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
Otvos James D.
EVP, Chief Scientific Officer
Transactions
- Conversion
Common Stock
2013-01-30+7,370→ 472,890 total - Conversion
Series C Convertible Preferred Stock
2013-01-30−12,652→ 0 total→ Common Stock (7,370 underlying)
Holdings
- 180,167(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Represents shares received upon conversion of shares of Series C convertible preferred stock.
- [F2]Effective immediately prior to the closing of the issuer's initial public offering of its common stock, each share of Series C convertible preferred stock automatically converted into approximately 0.582 shares of common stock. The convertible preferred stock had no expiration date.
- [F3]The Series C Convertible Preferred Stock converted into common stock on an approximately 0.582-for-1 basis and had no expiration date.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeother
Related Parties
1- filerCIK 0001530878
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:14 PM ET
- Size
- 8.1 KB